The XEGAFRI brand, founded in 2014 (United States), from 2 sister brands and 2214 competing brands. XEGAFRI is owned by Clovis Oncology, listed on the stock exchange of Francfort XEGAFRI is part of the Biotechnology activity sector.

XEGAFRI is a brand of Clovis Oncology (C6O) Share price

Share price and profitability of the share Clovis Oncology (XEGAFRI)

Buy Clovis Oncology share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Stock market history Clovis Oncology (XEGAFRI)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more